Literature DB >> 18562537

A replication-defective gammaherpesvirus efficiently establishes long-term latency in macrophages but not in B cells in vivo.

Haiyan Li1, Kazufumi Ikuta, John W Sixbey, Scott A Tibbetts.   

Abstract

Murine gammaherpesvirus 68 (gammaHV68 or MHV68) is genetically related to the human gammaherpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV), providing a useful system for in vivo studies of the virus-host relationship. To begin to address fundamental questions about the mechanisms of the establishment of gammaherpesvirus latency, we previously generated a replication-defective gammaHV68 lacking the expression of the single-stranded DNA binding protein encoded by orf6. In work presented here, we demonstrate that this mutant virus established a long-term infection in vivo that was molecularly identical to wild-type virus latency. Thus, despite the absence of an acute phase of lytic replication, the mutant virus established a chronic infection in which the viral genome (i) was maintained as an episome and (ii) expressed latency-associated, but not lytic replication-associated, genes. Macrophages purified from mice infected with the replication-defective virus harbored viral genome at a frequency that was nearly identical to that of wild-type gammaHV68; however, the frequency of B cells harboring viral genome was greatly reduced in the absence of lytic replication. Thus, this replication-defective gammaherpesvirus efficiently established in vivo infection in macrophages that was molecularly indistinguishable from wild-type virus latency. These data point to a critical role for lytic replication or reactivation in the establishment or maintenance of latent infection in B cells.

Entities:  

Mesh:

Year:  2008        PMID: 18562537      PMCID: PMC2519690          DOI: 10.1128/JVI.00186-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage.

Authors:  M Shimakage; M Kimura; S Yanoma; M Ibe; S Yokota; G Tsujino; T Kozuka; T Dezawa; S Tamura; A Ohshima; M Yutsudo; A Hakura
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

2.  Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus.

Authors:  M Y Sangster; D J Topham; S D'Costa; R D Cardin; T N Marion; L K Myers; P C Doherty
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Early establishment of gamma-herpesvirus latency: implications for immune control.

Authors:  Emilio Flaño; Qingmei Jia; John Moore; David L Woodland; Ren Sun; Marcia A Blackman
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

4.  A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge.

Authors:  Janice M Moser; Michael L Farrell; Laurie T Krug; Jason W Upton; Samuel H Speck
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.

Authors:  Scott A Tibbetts; Felipe Suarez; Ashley L Steed; Jacob A Simmons; Herbert W Virgin
Journal:  Virology       Date:  2006-06-21       Impact factor: 3.616

6.  Characterization of gammaherpesvirus 68 gene 50 transcription.

Authors:  S Liu; I V Pavlova; H W Virgin; S H Speck
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Role of B-cell proliferation in the establishment of gammaherpesvirus latency.

Authors:  Janice M Moser; Jason W Upton; Robert D Allen; Christopher B Wilson; Samuel H Speck
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma.

Authors:  P Monini; S Colombini; M Stürzl; D Goletti; A Cafaro; C Sgadari; S Buttò; M Franco; P Leone; S Fais; P Leone; G Melucci-Vigo; C Chiozzini; F Carlini; G Ascherl; E Cornali; C Zietz; E Ramazzotti; F Ensoli; M Andreoni; P Pezzotti; G Rezza; R Yarchoan; R C Gallo; B Ensoli
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

9.  Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.

Authors:  T T Wu; E J Usherwood; J P Stewart; A A Nash; R Sun
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

10.  A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity.

Authors:  Basak Kayhan; Eric J Yager; Kathleen Lanzer; Tres Cookenham; Qingmei Jia; Ting-Ting Wu; David L Woodland; Ren Sun; Marcia A Blackman
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

View more
  19 in total

1.  Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Authors:  Carrie B Coleman; Michael S Nealy; Scott A Tibbetts
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 2.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

3.  Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.

Authors:  Benson Yee Hin Cheng; Jizu Zhi; Alexis Santana; Sohail Khan; Eduardo Salinas; J Craig Forrest; Yueting Zheng; Shirin Jaggi; Janet Leatherwood; Laurie T Krug
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

4.  Interaction of Kaposi's sarcoma-associated herpesvirus ORF6 protein with single-stranded DNA.

Authors:  Sezgin Ozgur; Jack Griffith
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

5.  B Cell-Specific Expression of Ataxia-Telangiectasia Mutated Protein Kinase Promotes Chronic Gammaherpesvirus Infection.

Authors:  Eric J Darrah; Joseph M Kulinski; Wadzanai P Mboko; Gang Xin; Laurent P Malherbe; Stephen B Gauld; Weiguo Cui; Vera L Tarakanova
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

6.  Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses.

Authors:  Andrea M Siegel; Udaya Shankari Rangaswamy; Ruth J Napier; Samuel H Speck
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

7.  Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infection.

Authors:  Michael S Nealy; Carrie B Coleman; Haiyan Li; Scott A Tibbetts
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

8.  Identification and sequencing of a novel rodent gammaherpesvirus that establishes acute and latent infection in laboratory mice.

Authors:  Joy Loh; Guoyan Zhao; Christopher A Nelson; Penny Coder; Lindsay Droit; Scott A Handley; L Steven Johnson; Punit Vachharajani; Hilda Guzman; Robert B Tesh; David Wang; Daved H Fremont; Herbert W Virgin
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

9.  Suppression of TLR9 immunostimulatory motifs in the genome of a gammaherpesvirus.

Authors:  Andrea C Pezda; Alex Penn; Gregory M Barton; Laurent Coscoy
Journal:  J Immunol       Date:  2011-06-10       Impact factor: 5.422

10.  LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

Authors:  P T Lange; C N Jondle; E J Darrah; K E Johnson; V L Tarakanova
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.